BACKGROUND: Whether the benefits observed with cardiac resynchronization therapy
(CRT) are similar in patients with versus those without atrial fibrillation (AF) is unclear …

Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Aims The choice of resynchronization therapy between with (CRT-D) and without (CRT-P) a
defibrillator remains a contentious issue. Cause-of-death analysis among CRT-P, compared …

Aims Device-related infections (DRI) are not well understood in patients implanted with a
cardiac resynchronization therapy (CRT) device. The aims of this study were:(i) to evaluate …

BACKGROUND: Cardiac resynchronization therapy (CRT) decreases mortality, improves
functional status, and induces reverse left ventricular (LV) remodeling in selected …

Background—Data on sex difference in response to cardiac resynchronization therapy
(CRT) remain controversial. We conducted a meta-analysis to summarize all published …

Abstract Aims CHADS2 and CHA2DS2-VASc scores are pivotal in assessing the risk of
stroke in atrial fibrillation patients, and were recently proved to predict hospitalizations and …

Aims Comorbidity, such as myocardial infarction, diabetes, and renal failure, plays a pivotal
role in the prognosis of a patient with arrhythmias. However, data on the prognostic impact of …

Aims The beneficial effects of CRT in patients with advanced heart failure, wide QRS, and
low LVEF have been clearly established. Nevertheless, mortality remains high in some …

Aims The decision to implant a cardiac resynchronization therapy (CRT) system with
(defibrillator, CRT-D) or without (pacemaker, CRT-P) cardioverter defibrillator should weigh …